Symbol not found

:ATRX   00:00AM GMT
0.00
0.00 (0.00%)
Mergers / Acquisitions

Adhera Therapeutics Signs Letter Of Intent With Melior Pharmaceuticals Ii To Acquire A New Class Of Drug For Parkinson’S Disease

Published: 06/07/2021 13:19 GMT
(ATRX) - Adhera Therapeutics Signs Letter of Intent With Melior Pharmaceuticals Ii to Acquire a New Class of Drug for Parkinson’s Disease.